{"count": 208, "results": [{"_id": "33726685", "pmid": 33726685, "pmcid": "PMC7967963", "title": "A systematic review on pharmacokinetics, cardiovascular outcomes and safety profiles of statins in cirrhosis", "journal": "BMC Gastroenterol", "authors": ["Sung S", "Al-Karaghouli M", "Kalainy S", "Cabrera Garcia L", "Abraldes JG"], "date": "2021-03-16T00:00:00Z", "doi": "10.1186/s12876-021-01704-w", "meta_date_publication": "2021 Mar 16", "meta_volume": "21", "meta_issue": "1", "meta_pages": "120", "score": 50294.527, "text_hl": "The pooled estimate of @<m>DISEASE_Rhabdomyolysis</m> @DISEASE_MESH:D012206 @@@rhabdomyolysis@@@ or @DISEASE_Muscular_Diseases @DISEASE_MESH:D009135 @@@muscle injury@@@ with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ 40 mg was 4%, while it was 2% for @<m>DISEASE_Rhabdomyolysis</m> @DISEASE_MESH:D012206 @@@rhabdomyolysis@@@. ", "citations": {"NLM": "Sung S, Al-Karaghouli M, Kalainy S, Cabrera Garcia L, Abraldes JG. A systematic review on pharmacokinetics, cardiovascular outcomes and safety profiles of statins in cirrhosis BMC Gastroenterol. 2021 Mar 16;21(1):120. PMID: 33726685", "BibTeX": "@article{33726685, title={A systematic review on pharmacokinetics, cardiovascular outcomes and safety profiles of statins in cirrhosis}, author={Sung S and Al-Karaghouli M and Kalainy S and Cabrera Garcia L and Abraldes JG}, journal={BMC Gastroenterol}, volume={21}, number={1}, pages={120}}"}}, {"_id": "37240654", "pmid": 37240654, "pmcid": "PMC10219483", "title": "Reporting of Drug-Induced Myopathies Associated with the Combination of Statins and Daptomycin: A Disproportionality Analysis Using the US Food and Drug Administration Adverse Event Reporting System", "journal": "J Clin Med", "authors": ["Wei C", "Yin W", "He Z", "Wu B"], "date": "2023-05-18T00:00:00Z", "doi": "10.3390/jcm12103548", "meta_date_publication": "2023 May 18", "meta_volume": "12", "meta_issue": "10", "meta_pages": "", "score": 50279.477, "text_hl": "Statins in combination with @CHEMICAL_Daptomycin @CHEMICAL_MESH:D017576 @@@daptomycin@@@ might also increase the reporting rate of @<m>DISEASE_Rhabdomyolysis</m> @DISEASE_MESH:D012206 @@@rhabdomyolysis@@@, especially with @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@, @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@, and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@. ", "citations": {"NLM": "Wei C, Yin W, He Z, Wu B. Reporting of Drug-Induced Myopathies Associated with the Combination of Statins and Daptomycin: A Disproportionality Analysis Using the US Food and Drug Administration Adverse Event Reporting System J Clin Med. 2023 May 18;12(10):. PMID: 37240654", "BibTeX": "@article{37240654, title={Reporting of Drug-Induced Myopathies Associated with the Combination of Statins and Daptomycin: A Disproportionality Analysis Using the US Food and Drug Administration Adverse Event Reporting System}, author={Wei C and Yin W and He Z and Wu B}, journal={J Clin Med}, volume={12}, number={10}}"}}, {"_id": "37186323", "pmid": 37186323, "title": "Rhabdomyolysis and statins: a pharmacovigilance comparative study between statins.", "journal": "Br J Clin Pharmacol", "authors": ["Montastruc JL"], "date": "2023-04-27T00:00:00Z", "doi": "10.1111/bcp.15757", "meta_date_publication": "2023 Apr 27", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50276.15, "text_hl": "Among 10 657 reports with @<m>DISEASE_Rhabdomyolysis</m> @DISEASE_MESH:D012206 @@@rhabdomyolysis@@@ with statins, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ was the highest risk statin in comparison with others: ROR=2.20 (2.11-2.29). ", "citations": {"NLM": "Montastruc JL. Rhabdomyolysis and statins: a pharmacovigilance comparative study between statins. Br J Clin Pharmacol. 2023 Apr 27;():. PMID: 37186323", "BibTeX": "@article{37186323, title={Rhabdomyolysis and statins: a pharmacovigilance comparative study between statins.}, author={Montastruc JL}, journal={Br J Clin Pharmacol}}"}}, {"_id": "32727321", "pmid": 32727321, "title": "Severe rhabdomyolysis induced by possible drug-drug interaction between Ribociclib and Simvastatin.", "journal": "J Oncol Pharm Pract", "authors": ["Streicher C", "Daulange A", "Madranges N", "Vayre L"], "date": "2021-04-01T00:00:00Z", "doi": "10.1177/1078155220945365", "meta_date_publication": "2021 Apr", "meta_volume": "27", "meta_issue": "3", "meta_pages": "722-726", "score": 50274.957, "text_hl": "Severe @<m>DISEASE_Rhabdomyolysis</m> @DISEASE_MESH:D012206 @@@rhabdomyolysis@@@ induced by possible drug-drug interaction between @CHEMICAL_ribociclib @CHEMICAL_MESH:C000589651 @@@Ribociclib@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@.", "citations": {"NLM": "Streicher C, Daulange A, Madranges N, Vayre L. Severe rhabdomyolysis induced by possible drug-drug interaction between Ribociclib and Simvastatin. J Oncol Pharm Pract. 2021 Apr;27(3):722-726. PMID: 32727321", "BibTeX": "@article{32727321, title={Severe rhabdomyolysis induced by possible drug-drug interaction between Ribociclib and Simvastatin.}, author={Streicher C and Daulange A and Madranges N and Vayre L}, journal={J Oncol Pharm Pract}, volume={27}, number={3}, pages={722-726}}"}}, {"_id": "36824143", "pmid": 36824143, "pmcid": "PMC9941666", "title": "Corrigendum: Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report", "journal": "Front Oncol", "authors": ["Poumeaud F", "Fontanier A", "Dion J", "Mathevet Q", "Cointault O", "Uro-Coste E", "Marty C", "Dalenc F", "Girardie P", "Rataboul A"], "date": "2023-02-07T00:00:00Z", "doi": "10.3389/fonc.2023.1149399", "meta_date_publication": "2023", "meta_volume": "13", "meta_issue": "", "meta_pages": "1149399", "score": 50272.883, "text_hl": "Corrigendum: Severe toxic @<m>DISEASE_Rhabdomyolysis</m> @DISEASE_MESH:D012206 @@@rhabdomyolysis@@@ under combined @CHEMICAL_palbociclib @CHEMICAL_MESH:C500026 @@@palbociclib@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ treatment: A case report", "citations": {"NLM": "Poumeaud F, Fontanier A, Dion J, Mathevet Q, Cointault O, Uro-Coste E, Marty C, Dalenc F, Girardie P, Rataboul A. Corrigendum: Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report Front Oncol. 2023;13():1149399. PMID: 36824143", "BibTeX": "@article{36824143, title={Corrigendum: Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report}, author={Poumeaud F and Fontanier A and Dion J and Mathevet Q and Cointault O and Uro-Coste E and Marty C and Dalenc F and Girardie P and Rataboul A}, journal={Front Oncol}, volume={13}, pages={1149399}}"}}, {"_id": "33277702", "pmid": 33277702, "title": "Statin-induced rhabdomyolysis from azithromycin interaction in a patient with heterozygous SLCO1B1 polymorphism.", "journal": "J Clin Pharm Ther", "authors": ["Burns H", "Russell L", "Cox ZL"], "date": "2021-06-01T00:00:00Z", "doi": "10.1111/jcpt.13327", "meta_date_publication": "2021 Jun", "meta_volume": "46", "meta_issue": "3", "meta_pages": "853-855", "score": 50270.363, "text_hl": "The combination increases @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ serum concentrations significantly, inducing @<m>DISEASE_Rhabdomyolysis</m> @DISEASE_MESH:D012206 @@@rhabdomyolysis@@@. ", "citations": {"NLM": "Burns H, Russell L, Cox ZL. Statin-induced rhabdomyolysis from azithromycin interaction in a patient with heterozygous SLCO1B1 polymorphism. J Clin Pharm Ther. 2021 Jun;46(3):853-855. PMID: 33277702", "BibTeX": "@article{33277702, title={Statin-induced rhabdomyolysis from azithromycin interaction in a patient with heterozygous SLCO1B1 polymorphism.}, author={Burns H and Russell L and Cox ZL}, journal={J Clin Pharm Ther}, volume={46}, number={3}, pages={853-855}}"}}, {"_id": "36591506", "pmid": 36591506, "pmcid": "PMC9795206", "title": "Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report", "journal": "Front Oncol", "authors": ["François P", "Anna F", "Jérémie D", "Quentin M", "Olivier C", "Emmanuelle UC", "Céline M", "Florence D", "Pierre G", "Anaïs R"], "date": "2022-12-14T00:00:00Z", "doi": "10.3389/fonc.2022.1026434", "meta_date_publication": "2022", "meta_volume": "12", "meta_issue": "", "meta_pages": "1026434", "score": 50270.223, "text_hl": "Severe @DISEASE_Drug_Related_Side_Effects_and_Adverse_Reactions @DISEASE_MESH:D064420 @@@toxic@@@ @<m>DISEASE_Rhabdomyolysis</m> @DISEASE_MESH:D012206 @@@rhabdomyolysis@@@ under combined @CHEMICAL_palbociclib @CHEMICAL_MESH:C500026 @@@palbociclib@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ treatment: A case report", "citations": {"NLM": "François P, Anna F, Jérémie D, Quentin M, Olivier C, Emmanuelle UC, Céline M, Florence D, Pierre G, Anaïs R. Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report Front Oncol. 2022;12():1026434. PMID: 36591506", "BibTeX": "@article{36591506, title={Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report}, author={François P and Anna F and Jérémie D and Quentin M and Olivier C and Emmanuelle UC and Céline M and Florence D and Pierre G and Anaïs R}, journal={Front Oncol}, volume={12}, pages={1026434}}"}}, {"_id": "34267441", "pmid": 34267441, "pmcid": "PMC8240945", "title": "First Reported Case of Rhabdomyolysis Associated with Concomitant Use of Cyclosporin, Diltiazem, and Simvastatin", "journal": "Indian J Nephrol", "authors": ["Fuah KW", "Lim C"], "date": "2021-03-01T00:00:00Z", "doi": "10.4103/ijn.IJN_5_20", "meta_date_publication": "2021 Mar-Apr", "meta_volume": "31", "meta_issue": "2", "meta_pages": "173-175", "score": 50269.113, "text_hl": "First Reported Case of @<m>DISEASE_Rhabdomyolysis</m> @DISEASE_MESH:D012206 @@@Rhabdomyolysis@@@ Associated with Concomitant Use of @CHEMICAL_Cyclosporine @CHEMICAL_MESH:D016572 @@@Cyclosporin@@@, @CHEMICAL_Diltiazem @CHEMICAL_MESH:D004110 @@@Diltiazem@@@, and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@", "citations": {"NLM": "Fuah KW, Lim C. First Reported Case of Rhabdomyolysis Associated with Concomitant Use of Cyclosporin, Diltiazem, and Simvastatin Indian J Nephrol. 2021 Mar-Apr;31(2):173-175. PMID: 34267441", "BibTeX": "@article{34267441, title={First Reported Case of Rhabdomyolysis Associated with Concomitant Use of Cyclosporin, Diltiazem, and Simvastatin}, author={Fuah KW and Lim C}, journal={Indian J Nephrol}, volume={31}, number={2}, pages={173-175}}"}}, {"_id": "36718280", "pmid": 36718280, "pmcid": "PMC9883986", "title": "Rhabdomyolysis Induced by the Interaction Between Ribociclib and Statins- Case Report and Literature Review", "journal": "Breast Cancer (Dove Med Press)", "authors": ["Badran O", "Abu Amna M", "Turgeman I", "Bar-Sela G"], "date": "2023-01-24T00:00:00Z", "doi": "10.2147/BCTT.S380485", "meta_date_publication": "2023", "meta_volume": "15", "meta_issue": "", "meta_pages": "47-50", "score": 50268.562, "text_hl": "We describe a case of a 73-year-old @SPECIES_9606 @@@woman@@@ who developed @<m>DISEASE_Rhabdomyolysis</m> @DISEASE_MESH:D012206 @@@rhabdomyolysis@@@ following a drug-drug interaction due to the concomitant use of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_ribociclib @CHEMICAL_MESH:C000589651 @@@ribociclib@@@.", "citations": {"NLM": "Badran O, Abu Amna M, Turgeman I, Bar-Sela G. Rhabdomyolysis Induced by the Interaction Between Ribociclib and Statins- Case Report and Literature Review Breast Cancer (Dove Med Press). 2023;15():47-50. PMID: 36718280", "BibTeX": "@article{36718280, title={Rhabdomyolysis Induced by the Interaction Between Ribociclib and Statins- Case Report and Literature Review}, author={Badran O and Abu Amna M and Turgeman I and Bar-Sela G}, journal={Breast Cancer (Dove Med Press)}, volume={15}, pages={47-50}}"}}, {"_id": "40576487", "pmid": 40576487, "title": "Safety of Concomitant Use of Tacrolimus and High-Intensity Statins in Liver and Kidney Transplant Recipients.", "journal": "Prog Transplant", "authors": ["Klein K", "Klimatcheva M", "Hall R", "Patel R", "Speeg KV", "Guerrero J", "Long C"], "date": "2025-09-01T00:00:00Z", "doi": "10.1177/15269248251349768", "meta_date_publication": "2025 Sep", "meta_volume": "35", "meta_issue": "3", "meta_pages": "178-182", "score": 50255.0, "text_hl": "Due to increased risk of @DISEASE_Myalgia @DISEASE_MESH:D063806 @@@myalgia@@@ and @<m>DISEASE_Rhabdomyolysis</m> @DISEASE_MESH:D012206 @@@rhabdomyolysis@@@ associated with the use of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ with @CHEMICAL_Cyclosporine @CHEMICAL_MESH:D016572 @@@cyclosporine@@@, use of high-intensity 3-hydroxy-3-methylglutaryl Coenzyme A reductase inhibitors (statins) is often avoided in transplant recipients. ", "citations": {"NLM": "Klein K, Klimatcheva M, Hall R, Patel R, Speeg KV, Guerrero J, Long C. Safety of Concomitant Use of Tacrolimus and High-Intensity Statins in Liver and Kidney Transplant Recipients. Prog Transplant. 2025 Sep;35(3):178-182. PMID: 40576487", "BibTeX": "@article{40576487, title={Safety of Concomitant Use of Tacrolimus and High-Intensity Statins in Liver and Kidney Transplant Recipients.}, author={Klein K and Klimatcheva M and Hall R and Patel R and Speeg KV and Guerrero J and Long C}, journal={Prog Transplant}, volume={35}, number={3}, pages={178-182}}"}}]}